XBiotech Inc. (XBIT)

XBiotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	172.68	200.02	157.31	236.98	237.37
Short-Term Investments	-	-	60.17	-	-
Cash & Short-Term Investments	172.68	200.02	217.48	236.98	237.37
Cash Growth	-13.67%	-8.03%	-8.23%	-0.16%	-66.78%
Accounts Receivable	-	-	-	-	4.11
Other Receivables	0.86	0.94	1.76	8.95	6.57
Receivables	0.86	0.94	1.76	8.95	10.69
Prepaid Expenses	1.03	0.76	0.6	0.93	0.58
Other Current Assets	-	-	-	-	77.24
Total Current Assets	174.57	201.72	219.84	246.87	325.88
Property, Plant & Equipment	24.53	24.9	26.26	28.31	27.34
Long-Term Deferred Tax Assets	-	-	-	-	0.53
Total Assets	199.09	226.62	246.1	275.18	353.74
Accounts Payable	2.22	2.52	2.41	2.07	2.49
Accrued Expenses	2.63	3.5	1.6	1.37	1.35
Short-Term Debt	10.25	-	-	-	-
Current Income Taxes Payable	-	0.08	0.06	0.01	0.14
Total Current Liabilities	15.11	6.1	4.07	3.45	3.98
Long-Term Deferred Tax Liabilities	-	-	0.06	0.87	-
Other Long-Term Liabilities	1.72	1.67	1.58	1.47	1.12
Total Liabilities	16.83	7.77	5.7	5.79	5.11
Common Stock	273.11	271.15	267.33	262.26	249.81
Retained Earnings	-90.84	-52.31	-27.75	5.15	97.57
Comprehensive Income & Other	-	-	0.83	1.97	1.27
Shareholders' Equity	182.27	218.85	240.4	269.39	348.64
Total Liabilities & Equity	199.09	226.62	246.1	275.18	353.74
Total Debt	10.25	-	-	-	-
Net Cash (Debt)	162.43	200.02	217.48	236.98	237.37
Net Cash Growth	-18.80%	-8.03%	-8.23%	-0.16%	-66.78%
Net Cash Per Share	5.33	6.57	7.14	7.89	7.70
Filing Date Shares Outstanding	30.49	30.45	30.44	30.44	29.46
Total Common Shares Outstanding	30.49	30.44	30.44	30.44	29.3
Working Capital	159.46	195.62	215.78	243.42	321.89
Book Value Per Share	5.98	7.19	7.90	8.85	11.90
Tangible Book Value	182.27	218.85	240.4	269.39	348.64
Tangible Book Value Per Share	5.98	7.19	7.90	8.85	11.90
Land	1.42	1.42	1.42	1.42	1.42
Buildings	24.17	24.17	24.17	22.77	21.01
Machinery	17.03	16.89	16.57	17.6	15.2
Construction In Progress	1.71	0.47	0.4	2.06	2.63

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q